In this study, we elucidated the distinct roles of FASN and LDHA as pivotal players in aerobic and anaerobic metabolic pathways, respectively, within BC, correlating their expression profiles with disease progression, aggressiveness, and treatment responsiveness. The gene discussed is LDHA; the disease is breast cancer.